2019 Cardiovascular Update

May 31, 2019 Drew Lecture Hall Medical Services Building Athens, GA About the Conference

Welcome The Chapter of the American College of Cardiology (ACC) would like to invite you to attend the 2019 Car- diovascular Update. This meeting reflects our dedication to reducing cardiovascular risk and improving patient outcomes. Registered Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, and Clinical Pharmacists should participate in order to enhance their knowledge, improve assessment skills, and network with colleagues. At this meeting, you will have the opportunity to learn more about the latest research and clinical guideline updates in cardiovascular medicine and apply this information to your own clinical practice. We look forward to providing you with an individualized experience that meets all of your learning needs.

Kathi Davis, RN, CCCC Program Director

About the Conference Parking The conference registration desk will be open from The conference will be held in the Drew 7:00am - 3:00pm on Friday. The program will begin Lecture Hall which is located on the third floor of the promptly at 8:00am and continue until 3:00pm. Medical Services Building (#8 on the map below). You may park in the MSB parking lot and one of the CME All registrants will need to provide their member or non team will validate your parking ticket if needed. member ID# and email address. Each attendee will be sent an evaluation link from [email protected] following the course. Once the evaluation has been completed, you will be prompted to enter your name (as you would like for it to appear on your certificate) and your email address. Once this information has been submitted your certificate will be automatically sent to the email address you provided.

Attire Casual attire is appropriate throughout the conference.

Website Information regarding this meeting can be found on our website at www.accga.org under Educational Events in Georgia. Piedmont Athens Regional Medical Services Building, 242 King Avenue Athens, GA 30606

Directions to the can be found on our website: https://www.piedmont.org/locations/piedmont-athens/driving-directions Background psd created by ydlabs - www.freepik.com 2 Georgia ACC, Cardiovascular Update 2019 Friday, May 31, 2019 About the Piedmont Athens Region Conference Athens, GA FRIDAY, MAY 31, 2019

7:00am Breakfast, Registration, Exhibits

8:00am Opening Remarks Jeff Marshall, MD, FACC Governor GA ACC NE GA Health System Gainesville, GA

8:10am – 8:55am Cardiac Amyloidosis Andrew Darlington, DO Piedmont Heart Institute – Samsky Heart , GA

8:55am – 9:40am Cardiogenic Shock Tanveer Rab, MD, FACC Emory University Hospital Atlanta, GA

9:40am – 10:25am Prevention of Heart Disease and Stroke in Women Gina Lundberg, MD Emory University Hospital Atlanta, GA

10:25am - 10:45am Break and Exhibits

10:45am – 11:15am Antiplatelet Therapy After Percutaneous Coronary Intervention Paul Johnson, MD, FACC Piedmont Heart Institute Athens, GA

11:15am – 12:00pm What Every Provider Needs to Know About Preventive Cardiology Matthew Crim, MD, FACC Piedmont Heart Institute Athens, GA

12:00pm – 12:45pm Lunch

3 12:45pm – 1:30pm What Do Your ECHO Results Really Mean? Joseph Poole, MD Piedmont Heart Institute Athens, GA

1:30pm – 2:15pm Vascular FAQ’s Jonathan Woody, MD Athens, GA

2:15pm – 3:00pm Updated Hypertension Guidelines Kofi Osei, MD Piedmont Athens Hospitalist Group Athens, GA

Only sessions where education is occurring are eligible for CME credits. Breaks and meals without lectures are not eligible for CME credits. Official amount of credits will be determined by the CME Program.

Speakers and Objectives

Jeff Marshall, MD, FACC Andrew Darlington, DO Dr. Marshall received his medical degree from Dr. Darlington earned his medical de- University of Florida. He completed his resi- gree at the Philadelphia College of Os- dency in Internal Medicine, and his fellowship teopathic Medicine in Philadelphia. He in Cardiology and Angioplasty, at Medical completed his internship and residency College of Virginia. He is board certified in in Internal Medicine at the University of Internal Medicine, Cardiovascular Disease Florida College of Medicine in Jackson- and Interventional Cardiology. ville, where he was the Chief Medical Resident. Following his residency, he completed a Cardi- Dr. Marshall is the Chairman of The Heart Center of North- ology fellowship at the University of Florida and served east Georgia Medical Center (NGMC). He led the creation as the Chief Cardiovascular Fellow. of the angioplasty program at NGMC and a regional emergency heart attack response program called North- Dr. Darlington completed his fellowship training in Ad- east Georgia Regional STEMI System, which has received vanced Heart Failure and Transplant Cardiology at Yale national recognition for its life-saving work. University. He is board certified in Internal Medicine, Car- diovascular Medicine, Echocardiology and Nuclear Cardi- Dr. Marshall is former President of the Society for Car- ology. Dr. Darlington is a fellow of the American College diovascular Angiography and Interventions (SCAI), which of Cardiology and a member of the International Society recognized him as a Master Interventionalist (MSCAI) in of Heart and Lung Transplantation and Cardiomyopathy. 2016. He also previous served on the faculty at Emory He has a special interest in Congestive Heart Failure and University, where he was an associate professor of Medi- Cardiomyopathy. In his spare time, Dr. Darlington enjoys cine and Cardiology for 11 years, as well as the faculty at all sports as well as traveling with his family. Medical College of Virginia. 4 Cardiac Amyloidosis ber for Atlanta chapter from 2001 till 2007. Dr. Lundberg Amyloidosis is a multisystem disease that is often misdiag- was the Honoree for American Heart Association’s North nosed, with diagnosis previously occurring after death during Fulton/ Gwinnett County Heart Ball for 2006. In 2009 she the autopsy. However, recent advancement of technologies was awarded the Women with Heart Award at the Go Red have increased the diagnosis of the disease. The prognosis Luncheon for outstanding dedication to the program. She is depends on the extent of the protein deposits in the body also a Circle of Red founding member and Cor Vitae member and the type of amyloidosis. Providers will need to be aware for AHA. She has been interviewed on the subject of Heart of the testing available to differentiate the type and the Disease in Women in various media channels including CNN treatment options that are available. Objectives: After par- and in USA Today. Governor Sonny Perdue appointed Dr. Lun- ticipating in this activity, learners will be able to: 1) Explain dberg to the Advisory Board for the Department of Women’s the pathophysiology of amyloid disease and different phe- Health for the State of Georgia in 2007 till 2011. In 2005, notypes. 2) Describe the differences in AL amyloid and TTR Atlanta Woman Magazine awarded Dr. Lundberg the Top 10 amyloid- wild type or inherited. Innovator Award for Medicine. In 2008 Atlanta Woman Maga- zine named her one of the Top 25 Professional Women to Watch and the only woman in the field of medicine. S. Tanveer Rab, MD, FACC Dr. S. Tanveer Rab is a Professor and an In- She attended the Medical College of Georgia and trained in terventional Cardiologist at Emory University Internal Medicine at (Georgia Baptist). in Atlanta, Georgia. He received his Medical Her cardiology fellowship was at Rush University in Chicago. degree in 1979 from the University of Karachi She has been in practice in Atlanta since 1994. She is Board Pakistan. Between 1983 and 1986 he com- Certified in Cardiology and Internal Medicine and recertified pleted residency training in Internal Medicine in both in 2002. at the Henry Ford Hospital in Detroit, Michi- gan. He trained at Emory University between 1986-1990 in Prevention of Heart Disease and Stroke in Women Cardiology and Interventional Cardiology and joined its faculty Providers should be knowledgeable on optimal risk factor as- in 1988 where he is extensively involved in the training and sessment and management of the female population. They teaching of general cardiology and interventional cardiology should also be knowledgeable of the appropriate therapies fellows. He is Board Certified in Medicine, Cardiology and In- that are available for disease prevention. Objectives: After terventional Cardiology and is a Fellow of the American Col- participating in this activity, learners will be able to: 1) lege of Cardiology and Society of Coronary Angiography and Learners will gain knowledge on optimal risk factor manage- Interventions. ment for the female population. 2) Learners will gain knowl- edge on optimal pharmacological therapies for women in the Dr. Rab currently serves in the Publications Committee and prevention of heart disease and stroke. the Leadership Committee of the Interventional Section Leadership Council of the American College of Cardiology, where he is the chair of the complex angioplasty group. He was the former chair of the Interventional Section’s publica- Paul Johnson, MD, FACC tion committee, having authored or coauthored twelve peer Dr. Johnson earned his medical degree from reviewed articles on topics of importance to the interven- the Medical College of Georgia and com- tional community. pleted residency, cardiology fellowship, and interventional cardiology fellowship at the Cardiogenic Shock University of North Carolina (UNC) . Providers should be able to recognize the clinical symptoms He also served as Chief Resident in Internal associated with cardiogenic shock, utilize and apply ap- Medicine and Chief Cardiology Fellow at propriate pharmacologic and interventional therapies and while UNC. Dr. Johnson is board certified in Internal Medicine, manage such therapies. Objectives: After participating in this Cardiovascular Disease, Echocardiography, Nuclear Cardiol- activity, learners will be able to: 1) Increase understanding ogy, and Interventional Cardiology. He is a Fellow of the of the pathophysiology of cardiogenic shock. 2) Increase un- American College of Cardiology and Clinical Assistant Profes- derstanding of the management principles and interventional sor with the /University of Georgia Medical therapies for cardiogenic shock. Partnership.

Antiplatelet Therapy After Percutaneous Coronary Gina Lundberg, MD Intervention Dr. Lundberg is the Clinical Director of the Providers need to be aware of the current guideline recom- Emory Women’s Heart Center and a Preven- mendations for DAPT use after PCI for stable angina and tive Cardiologist with Emory Clinic in East acute coronary syndrome. Providers also need to recognize Cobb. Dr. Lundberg is an Associate Professor controversies regarding DAPT use, including duration of of Medicine at Emory University School of treatment and options for treatment in patients with an indi- Medicine. She is a National American Heart cation for oral anticoagulation. Objectives: After participat- Association (AHA) spokesperson and has been a Board Mem- ing in this activity, learners will be able to: 1) Describe the

5 Speakers and Objectives

available antiplatelet agents used after percutaneous coronary of reduced LV systolic function as an independent predictor of intervention. 2). Explain when prasugrel or ticagrelor should be mortality. 2) More capably relay cardiovascular disease preven- used instead of clopidogrel. tion measures to patients regarding “incidental” findings on an echocardiogram report. Matthew Crim, MD, FACC Dr. Crim is board certified in Cardiovascular Dis- Jonathan Woody, MD ease, Internal Medicine, Echocardiography, and Dr. Jonathan Woody is a vascular surgeon in Nuclear Cardiology. He is an Assistant Professor of Athens, Georgia and is affiliated with multiple Medicine with the Augusta University/University hospitals in the area, including Piedmont Ath- of Georgia Medical Partnership, a fellow of the ens Regional Medical Center and St. Mary’s American College of Cardiology, and a member of Health Care System-Athens. He received his the American Heart Association. Dr Crim earned medical degree from Wake Forest School of his medical degree from Johns Hopkins. He completed his resi- Medicine and has been in practice for more dency in internal medicine at Johns Hopkins, and fellowship in car- than 20 years. He is one of 5 doctors at Piedmont Athens Re- diology at Emory. Dr. Crim is a cardiologist at the Piedmont Heart gional Medical Center and one of 5 at St. Mary’s Health Care Insitute in Athens, GA. System-Athens who specialize in Vascular Surgery. What Every Provider Needs to Know About Preventive Cardiology Vascular FAQ’s All providers should be knowledgeable about and educate Providers should be aware of the risk factors associated with PAD patients regarding cardiovascular health risk factors to reduce as 66% of patients affected do not have symptoms or have atypi- atherosclerotic cardiovascular disease morbidity and mortality. cal symptoms. Providers should also be knowledgeable of find- Providers should also be knowledge of available risk calcula- ings that are associated with PAD on physical exam and what the tors and testing options to refine risk prediction, and updated appropriate confirmatory testing should be. Providers should be strategies to enhance cardiovascular health as offered by the aware of the most recent guidelines associate with PAD. AHA and ACC guidelines. Objectives: After participating in this activity, learners will be Objectives: After participating in this activity, learners will be able to: 1) Describe the management of Peripheral Arterial Dis- able to: 1) Describe the American Heart Association’s “Like ease. Simple 7” factors for ideal cardiovascular health. 2) Discuss the 2) Define a PAD emergency. role of coronary artery calcium scoring in coronary artery disease prevention. Kofi Osei, MD Dr. Osei, MD is a practicing Internist in Athens, Joseph Poole, MD, FACC GA. Dr. Osei graduated from University of Ghana Dr. Poole earned his medical degree and a PhD School of Medicine & Dentistry in 2009 and has in Vascular Biology from the Medical College been in practice for 9 years. He completed a resi- of Georgia in 2008. He completed his Internal dency at St Vincents Medical Center. Dr. Osei is in medicine residency and Cardiology fellow- practice in Athens, GA. ship at Emory University School of Medicine in 2015. He received his undergraduate degree Updated Hypertension Guidelines from Duke University. Dr. Poole is board certi- Providers should be aware of updated ACC/AHA guidelines on fied in Internal Medicine and Cardiovascular the management of hypertension. The failure to recognize Diseases. He has additional certifications in Adult Echocardiog- these developments and the appropriate timing and sequence raphy, Vascular Medicine and Nuclear Cardiology. He has a spe- of initiating therapies can lead to varied patient outcomes. cial interest in the effects of aging on the cardiovascular system Providers need to stay informed of pharmacologic advances and additional expertise in the field of Cardio-oncology. and ACC/AHA recommendations for management of hyperten- sion in the clinical setting. Objectives: After participating in this What Do Your ECHO Results Really Mean? activity, learners will be able to: 1) Learners will gain knowledge Providers should be knowledgeable of what echocardiogram on optimal risk factor management related to blood pressure as findings warrant the initiation of therapy or should warrant fur- established by the most current guidelines. 2) Learners will gain ther investigation. Providers should also be knowledgeable of knowledge of the appropriate pharmacologic therapies to treat what therapies are available. Objectives: After participating in hypertension based on the most current guideline. this activity, learners will be able to: 1) Explain the implications 6 Statement of Need: The practice of clinical cardiology is evolving rapidly. Managing the needs of the cardiovascular patient has become increasingly complex. Utilizing the guidelines for the management and treatment of the CV patient is prominent in maintaining the highest quality of patient care.

Goal Statement: The goal of this event is to provide evidence-based, relevant information regarding the evaluation and treat- ment of cardiovascular disease in the clinical setting. Cardiovascular Team members will participate in didactic lectures as well as an interactive assessment workshop to enhance their scientific knowledge and clinical skills.

Educational Design: CVT members will participate in didactic lectures as well as interactive workshops to enhance their scientific knowledge and assessment skills.

Target Audience: The target audience for this course is Cardiologists, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants and Pharmacists that are based in a hospital or private practice.

Credit Statement: The Georgia Chapter of the American College of Cardiology is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.

The Georgia Chapter of the American College of Cardiology designates this live activity for a maximum of 5.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their par- ticipation in the activity.

Program Director: Activity Program Director Kathi Davis, NP-CCCC Piedmont Healthcare Cardiovascular Nurse Practitioner

7 American College of Cardiology, GA Chapter 4850 Golden Parkway Suite B-418 Buford, GA 30518

Registration

2019 Cardiovascular Update Provided by the The Georgia Chapter of the American College of Cardiology

May 31, 2019 Piedmont Athens Regional Medical Services Building Athens, GA

Members: $75 Non-Members $95

To register for the 2019 Cardiovascular Update, please type this link into your browser:

https://www.123signup.com/register?id=rzcxs

Please click the GA ACC Member option to get the discounted member rate.

Georgia Chapter of the American College of Cardiology 4850 Golden Parkway, Suite B-418, Buford, Georgia 30518 Telephone: 770.271.0798 Fax: 770.271.0634